Enlivex Ltd. (ENLV)
ENLVNASDAQ-CMBiotechnology: Pharmaceutical Preparations
$1.21
-0.0850 (-6.56%) today
Closed, Nov 12, 4:00 PM ET
- Market cap
- $1.91m
- P/E
- –
- EPS, last 4 quarters
- –
- Dividend yield
- –
- Day range
- –
- 52-week range
- $1.18 to $434.37
- Average volume
- –
- Previous close
- $1.30
Earnings
next estimate $-4.48Next report Nov 13, 2026
Financials
No quarterly figures from the source.
News
8 latest- Weekly Buzz: RDY, LUPIN, SUNPHARMA Score FDA Wins; AGIO, RARE Slash Jobs; CVS Plots Split RTTNews · 7 days ago
- Enlivex's Allocetra Shows Durable Benefit In Phase 2a Knee Osteoarthritis Study; Stock Down RTTNews · Nov 2, 2026
- Enlivex Reports 79% Response Rate With Allocetra In Older Knee OA Patients RTTNews · Nov 2, 2026
- Enlivex Consensus Price Target Increased by 1,500% to $1,305.60Fintel · Nov 1, 2026
- Enlivex Randomizes 135 Patients In Phase 2b Knee Arthritis Trial; Data Due By Mid-2027 RTTNews · Oct 29, 2026
- Enlivex Therapeutics Ltd. Announces Randomization of 135 Patients in Phase 2b Trial of AllocetraFintel · Oct 28, 2026
- Enlivex Therapeutics Ltd. Receives Nasdaq Delisting Notice and Announces 1-for-16 Reverse SplitFintel · Oct 27, 2026
- Weekly Buzz: AZN, ALVO Score FDA Nod; EYPT Cuts Jobs; RHHBY, GEHC Enter Deal; VERA Posts Trial Win RTTNews · Oct 23, 2026
The company
Enlivex is a quality longevity company powered by a prediction markets treasury. The Company is advancing Allocetra, an advanced clinical-stage immunotherapy targeting inflammatory conditions associated with aging, with a primary focus on age-related osteoarthritis. In addition to its clinical programs, Enlivex operates a prediction markets treasury strategy built around the Rain protocol, the leading decentralized prediction markets infrastructure on Arbitrum. This dual strategy combines the development of quality longevity therapeutics with exposure to the emerging prediction markets ecosystem.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ-CM
- Region
- Middle East
- Website
- enlivex.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.